Frontier Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Frontier Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$81K	Hold	10,000	–	–	0.01%	380
2022 Q1	$120K	Hold	10,000	–	–	﹤0.01%	389
2021 Q4	$281K	Hold	10,000	–	–	0.02%	339
2021 Q3	$340K	Hold	10,000	–	–	0.02%	311
2021 Q2	$409K	Buy	+10,000	New	+$389K	0.03%	286
2021 Q1	–	Sell	-10,000	Closed	-$591K	–	381
2020 Q4	$591K	Hold	10,000	–	–	0.05%	204
2020 Q3	$486K	Hold	10,000	–	–	0.04%	218
2020 Q2	$484K	Hold	10,000	–	–	0.04%	215
2020 Q1	$278K	Buy	+10,000	New	+$279K	0.05%	225

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Frontier Wealth Management's ADPT Position: Q2 2022 in Review

Frontier Wealth Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2022 at 10,000 shares worth $81K. The position accounts for 0.01% of the portfolio, ranked #380.

Frontier Wealth Management first reported a position in ADPT in Q1 2020 and has held it in 9 quarters since. The position peaked at $591K in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

Frontier Wealth Management held 10,000 shares of Adaptive Biotechnologies worth $81K as of Q2 2022.
Frontier Wealth Management left its Adaptive Biotechnologies share count unchanged in Q2 2022.
Adaptive Biotechnologies made up 0.01% of Frontier Wealth Management's portfolio in Q2 2022, its #380 holding.
Frontier Wealth Management first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 9 quarters since.
Frontier Wealth Management's Adaptive Biotechnologies position peaked at $591K in Q4 2020.
209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.